Delivery Order SPE2D021DA002-SPE2D325F028U
- Not listed
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1,636.62 to DMS Pharmaceutical Group Inc. for the supply of Twinrix vaccine in syringe format. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and will be performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $4,091.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Twinrix vaccine in syringe form. This firm fixed-price delivery order, issued on June 16, 2025, with an ultimate completion date of June 20, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 on July 24, 2025, for the supply of Twinrix vaccine syringes. This firm fixed-price delivery order, which is expected to be completed by July 29, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 by the Defense Logistics Agency's Medical Supply Chain division for TWINRIX vaccine syringes. The award, issued on July 21, 2025, with an ultimate completion date of July 24, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for $1,636.62 on April 23, 2025, with a completion date of April 24, 2025. The award covers the supply of Twinrix vaccine syringes under a firm fixed-price delivery order structure. This award was issued without a set-aside designation and represents a draw-down from DMS Pharmaceutical Group's larger indefinite delivery contract vehicle with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 on July 24, 2025, for the supply of Twinrix vaccine syringes. The order, with an ultimate completion date of July 29, 2025, was issued under a firm fixed-price contract type with no set-aside designation. The place of performance is Park Ridge, Illinois, and the award was funded by the Defense Logistics Agency's Medical Supply Chain...
- The Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a delivery order to DMS Pharmaceutical Group Inc. for Twinrix vaccine syringes valued at $2,454.93. The award, issued on September 9, 2025, with an ultimate completion date of September 12, 2025, carries firm fixed-price terms under a delivery order contract type with no set-aside designation. Performance will take place at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,808.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TWINRIX VACCINE SYRINGE and has an ultimate completion date of August 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Twinrix vaccine in syringe format. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received this contract award on August 13, 2025, with an ultimate completion date of August 18, 2025. The ceiling value for this delivery order is $1,636.62, and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,813.04 to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Twinrix vaccine syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its headquarters location with an ultimate completion date of September 8, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, allowing the...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F028UDelivery Order
The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,636.62 to DMS Pharmaceutical Group Inc. for the supply of TWINRIX vaccine syringes. The award, made on April 30, 2025, with an ultimate completion date of May 1, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is the prime contractor on this procurement. The company will perform the delivery at its facility in Park Ridge, IL 60068. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion blanket purchasing agreement valid through November 2026 that enables issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products and medical supplies supporting military healthcare facilities worldwide. TWINRIX, a combined hepatitis A and B vaccine, represents one of the routine immunization products within the broader portfolio of prescription medications, biologics, and medical consumables that DMS Pharmaceutical Group supplies to Department of Defense healthcare sites. As an established pharmaceutical distributor to federal agencies since 2001, the company maintains a significant role in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 4/30/25 |